ORN Spring 2024 - Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period-Recording: Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period

Recording: Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period

Back to course

Video Transcription

Video Summary

In today's webinar, Dr. Marcella Smith discussed maternal morbidity and mortality associated with methamphetamine and other substance use in the perinatal period. Key points included the increasing prevalence of methamphetamine and opioid use disorders, the impact on maternal and perinatal outcomes, and the importance of harm reduction strategies. Dr. Smith highlighted evidence-informed treatments, such as contingency management and pharmacological interventions, while also emphasizing the need for individualized care and addressing barriers like child removal and stigma. The webinar also covered research on the prevention of relapse to substance use in postpartum women and discussions on breastfeeding, medication use, and behavioral interventions. Attendees were encouraged to complete the survey for CME certificates and to join next week's webinar on opioid use disorder and youth. Dr. Smith's presentation was commended for its comprehensive and current information.

Keywords

maternal morbidity

maternal mortality

methamphetamine use

substance use disorder

perinatal period

harm reduction strategies

contingency management

pharmacological interventions

individualized care